Drugs & medicalClass II

Teva Pharmaceuticals USA Inc recalls Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ…

Failed Moisture Limits: Water (moisture) content above the approved product specifications.

Read the official notice →
Date
2023-07-19
Country
United States
Brand
Teva Pharmaceuticals
Product
Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC…
Classification
Class II
Units
Product was distributed to 3 wholesalers/distributors who further distributed…
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Teva Pharmaceuticals recalls

  1. 2024-02-21
  2. US
    Drugs & medicalClass III

    Teva Pharmaceuticals USA, Inc recalls Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each…

    Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

    FDA · DrugTeva Pharmaceuticals USA, IncnationwideOfficial notice →
  3. 2024-02-07
  4. US
  5. 2023-12-06
  6. US
  7. 2023-05-31
  8. US
  9. 2023-04-12
  10. US
    Drugs & medicalClass III

    Teva Pharmaceuticals USA Inc recalls Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva…

    Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.

    FDA · DrugTeva Pharmaceuticals USA IncUSA NationwideOfficial notice →
  11. 2023-03-22
  12. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA Inc recalls Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL…

    Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.

    FDA · DrugTeva Pharmaceuticals USA IncNationwide in the U.S.A.Official notice →
All 44 Teva Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2023-07-19
  2. US
    Drugs & medicalClass II

    B. Braun Medical Inc. recalls 0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, Rx only, B. Braun Medical Inc. Bethlehem, PA 18018-3524 USA, NDC…

    Lack of assurance of sterility: bags have the potential to leak.

    FDA · DrugB. Braun Medical Inc.USA NationwideOfficial notice →
  3. US
    Drugs & medicalClass II

    Tenn South Distillery LLC dba Big Machine Distillery recalls Big Machine Distillery Hand Sanitizer Non-Sterile Solution Alcohol Antiseptic 80% Topical Solution,…

    CGMP Deviation: impurities exceed allowable limits.

    FDA · DrugTenn South Distillery LLC dba Big Machine DistilleryTNOfficial notice →
  4. US
    Drugs & medicalClass II

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Tiagabine Hydrochloride Tablets, 2 mg, 30-count bottle, Distributed by Sun Pharmaceutical Industries. Inc. Cranbury NJ 08512,…

    Failed Impurities: Out of Specification (OOS) result observed during Related Substances testing

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCDistributed nationwide in the USA.Official notice →
  5. US
  6. US
    Drugs & medicalClass III

    Lupin Pharmaceuticals Inc. recalls Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland…

    Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.

    FDA · DrugLupin Pharmaceuticals Inc.Product was distributed directly to three distributors in TN and NJ. Product…Official notice →
  7. US
    Drugs & medicalClass II

    K.C. Pharmaceuticals, Inc recalls Dry Eye Relief Lubricant Eye Drops, (Glycerin 0.2%, Hypromellose 0.2 %, Polyethylene glycol 400 1%), 0.5 FL OZ (15mL) bottle, packaged…

    CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.

    FDA · DrugK.C. Pharmaceuticals, IncNationwide in the USAOfficial notice →
See all drugs & medical recalls →